Lactoylglutathione promotes inflammatory signaling in macrophages through histone lactoylation.

Metabolism glyoxalase inflammation lactate post-translational modification

Journal

Molecular metabolism
ISSN: 2212-8778
Titre abrégé: Mol Metab
Pays: Germany
ID NLM: 101605730

Informations de publication

Date de publication:
31 Jan 2024
Historique:
received: 03 11 2023
revised: 25 01 2024
accepted: 26 01 2024
medline: 3 2 2024
pubmed: 3 2 2024
entrez: 2 2 2024
Statut: aheadofprint

Résumé

Chronic, systemic inflammation is a pathophysiological manifestation of metabolic disorders. Inflammatory signaling leads to elevated glycolytic flux and a metabolic shift towards aerobic glycolysis and lactate generation. This rise in lactate corresponds with increased generation of lactoylLys modifications on histones, mediating transcriptional responses to inflammatory stimuli. Lactoylation is also generated through a non-enzymatic S-to-N acyltransfer from the glyoxalase cycle intermediate, lactoylglutathione (LGSH). Here, we report a regulatory role for LGSH in mediating histone lactoylation and inflammatory signaling. In the absence of the primary LGSH hydrolase, glyoxalase 2 (GLO2), RAW264.7 macrophages display significant elevations in LGSH and histone lactoylation with a corresponding potentiation of the inflammatory response when exposed to lipopolysaccharides. An analysis of chromatin accessibility shows that lactoylation is associated with more compacted chromatin than acetylation in an unstimulated state; upon stimulation, however, regions of the genome associated with lactoylation become markedly more accessible. Lastly, we demonstrate a spontaneous S-to-S acyltransfer of lactate from LGSH to CoA, yielding lactoyl-CoA. This represents the first known mechanism for the generation of this metabolite. Collectively, these data suggest that LGSH, and not intracellular lactate, is the primary driving factor facilitating histone lactoylation and a major contributor to inflammatory signaling.

Identifiants

pubmed: 38307385
pii: S2212-8778(24)00019-X
doi: 10.1016/j.molmet.2024.101888
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

101888

Informations de copyright

Copyright © 2024 The Author(s). Published by Elsevier GmbH.. All rights reserved.

Auteurs

Marissa N Trujillo (MN)

Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, Arizona 85721, USA.

Erin Q Jennings (EQ)

Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, Arizona 85721, USA.

Emely A Hoffman (EA)

Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, Arizona 85721, USA.

Hao Zhang (H)

Department of Cellular and Molecular Medicine, University of Arizona, Tucson, AZ, USA.

Aiden M Phoebe (AM)

Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, Arizona 85721, USA.

Grace E Mastin (GE)

Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, Arizona 85721, USA.

Naoya Kitamura (N)

Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, Arizona 85721, USA.

Julie A Reisz (JA)

Department of Biochemistry and Molecular Genetics, University of Colorado Denver - Anschutz Medical Campus, Aurora, CO 80045, USA.

Emily Megill (E)

Center for Metabolic Disease Research, Department of Cardiovascular Sciences, Temple University, Philadelphia, PA.

Daniel Kantner (D)

Center for Metabolic Disease Research, Department of Cardiovascular Sciences, Temple University, Philadelphia, PA.

Mariola M Marcinkiewicz (MM)

Center for Metabolic Disease Research, Department of Cardiovascular Sciences, Temple University, Philadelphia, PA.

Shannon M Twardy (SM)

Department of Pharmaceutical Sciences, The Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.

Felicidad Lebario (F)

Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, Arizona 85721, USA.

Eli Chapman (E)

Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, Arizona 85721, USA.

Rebecca L McCullough (RL)

Department of Pharmaceutical Sciences, The Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.

Angelo D'Alessandro (A)

Department of Biochemistry and Molecular Genetics, University of Colorado Denver - Anschutz Medical Campus, Aurora, CO 80045, USA.

Nathaniel W Snyder (NW)

Center for Metabolic Disease Research, Department of Cardiovascular Sciences, Temple University, Philadelphia, PA.

Darren A Cusanovich (DA)

Department of Cellular and Molecular Medicine, University of Arizona, Tucson, AZ, USA; Asthma and Airway Disease Research Center, University of Arizona, Tucson, AZ, USA.

James J Galligan (JJ)

Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, Arizona 85721, USA. Electronic address: jgalligan@pharmacy.arizona.edu.

Classifications MeSH